A comparitive study between placental extract versus silver sulfadiazine in 20-40 % fresh flame burns and scalds by Dhanaraj, P
A COMPARITIVE STUDY BETWEEN PLACENTAL   
EXTRACT VERSUS SILVER SULFADIAZINE IN  
 20– 40 % FRESH FLAME BURNS AND SCALDS  
 
                                                            
 
 
 
 
 
 
 
Dissertation submitted in partial fulfilment of regulation for 
 
 The Award of   M.S. Degree in General Surgery (Branch I) 
 
                                                             
 
 
 
 
 
 
 
 
                            THE TAMILNADU 
 
                   DR. M.G.R. MEDICAL UNIVERSITY 
 
                               CHENNAI- APRIL, 2013. 
 
                COIMBATORE MEDICAL COLLEGE HOSPITAL 
 
                               CERTIFICATE 
 
This is to certify that this is the bonafide dissertation done by Dr. Dhanaraj P. 
 
and submitted in partial fulfilment of the requirements for the Degree of 
 
M. S. General Surgery, Branch I of The Tamilnadu Dr .M .G .R. Medical  
 
University, Chennai. 
 
 
 
 
 
 
Date   :                                                                             Professor and Chief  
                                                                                        Surgical Unit-VI  
 
 
 
 
Date   :                                                                            Professor and Head     
                                                                                    Department of Surgery 
 
 
 
 
 
Date   :                                                                                      DEAN 
                                                                            Coimbatore Medical College 
                                                                                             Coimbatore.              
                               DECLARATION 
 
I solemnly declare that the dissertation titled  “ A Comparative Study 
between placental extract versus silver sulfadiazine in 20 – 40% fresh 
flame burns and scalds ” at Coimbatore Medical College Hospital  was  
done by  me from  January  2011 to  August  2012  under the guidance and  
supervision of Professor  DR .G. RAVINDRAN, M.S., This dissertation is 
submitted to the Tamilnadu Dr . M. G. R.   Medical University towards the 
partial fulfilment of the requirement for the award of M.S Degree in General 
Surgery (Branch I).   
 
 
 
Place: Coimbatore                                                          DR. P. DHANARAJ 
 
Date   :  
 
                                                                                                 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ACKNOWLEDGEMENT 
       I thank Dr. VIMALA M.D, Dean, Coimbatore Medical College and 
Hospital, Coimbatore for having allowed me to do this study in this Hospital. 
       I am immensely thankful to Prof. Dr. P.V. VASANTHAKUMAR M.S., 
Professor and Head of the department of surgery for his excellent guidance in 
conducting this study. 
          I take this opportunity to express my deep gratitude to my beloved chief, 
Prof. Dr. G. RAVINDRAN M.S., Professor of surgery whose guidance and 
criticism have seen me through this study. 
        I would also like to express my thanks to all other Unit Chiefs 
Prof. Dr. V. ELANGO M.S, Prof. Dr. P. SWAMINATHAN M.S, 
Prof. Dr. D. N. RENGANATHAN M.S, Prof. Dr. S. NATARAJAN M.S, 
 for extending their full support and  allowing me to use their patient in this 
study. 
         I do convey my sincere thanks to our unit Assistant Professors              
 Dr. G.VISWANATHAN M.S, and Dr. S. MUTHULAKSHMI M.S, for their 
advice and guidance. 
     I would also like to extend my heartfelt gratitude to all the assistant 
professors for all the valuable support and guidance they extended to me. 
     I thank all the patients whose patience and co-operation has made   this work 
possible. 
 
INDEX 
 
SL.NO PARTICULARS PAGE NO 
1 INTRODUCTION     1 
2 REVIEW OF LITERATURE                                                4
3 AIM OF THE STUDY 69 
4 MATERIALS AND METHODS 70 
5 OBSERVATION AND RESULTS 73 
6 DISCUSSION 
 
86 
7     CONCLUSION 
 
90 
8 ANNEXURES 91 
 
 • 1 
 
INTRODUCTION 
o Around the world burns are a major cause of health problems as the 
problem lies not only with the immediate cause but as the patient survives 
he has to carry the physical and psychological morbidity associated with 
it. 
o 95% of deaths due to burns have been reported in middle and low 
socioeconomic countries. 
o Ever since man had found out about fire, burn injuries have existed the 
earliest documentary evidence seen in the Ebers Papyrus. 
o Since then various people have proposed several different methods to 
treat burn injuries. 
o Susrutha of India during ancient times had classified and described Burns 
into four categories .He also used honey as antiseptic to treat burn 
wounds.   
o Dupuytren, the famous French surgeon wrote at the beginning of the 19th 
century that “burns had been the object of one of the most bizarre 
treatment methods”. 
o The Egyptian’s treated burns by incantations and a mixture of gum, 
goat’s hair and milk from women who had given birth to child.   
o Chinese and Japanese used extract of tea leaves. 
o Hippocrates suggested the use of warm vinegar and solution of oak bark. 
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o Celsus described use of honey and Galen prescribed vinegar. 
o Rhazes used ice cold water 
o Humans have always depended on fire either to prepare food or for  
warmth , but fire being a double edged sword is associated with injuries 
which have been one of the earthly evils. So it is this fire which is both 
blessing and scourge to mankind.  
         
o Burns are tissue injuries resulting from direct contact with flames, hot 
liquids, chemicals, and electricity or radiation .Most commonly skin is 
injured. 
o  Skin loses its function as a barrier to injury and infection and as a 
regulator of temperature, fluid loss and sensation.  
o Pathologically burn injury causes coagulative necrosis to tissues.  
o Rarely, burn injures the deeper tissues and vascular structures. 
o Heat is transferred to the tissues by conduction from contact with hot 
liquids and solids and convection of hot gases over the skin. 
 (Flame, radiation) or from a sudden release of great energy as in 
electric arc or explosion. 
o Burn injury carried a poor prognosis in the past.  
o With the understanding of the patho physiology and advances in fluid 
resuscitation and early excision of the burns wound, survival of the 
patient improved in recent times. 
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o  Management of burns is done in  two stages 
1)Immediate management  
2)Late management 
 
• Immediate 
 Fluid resuscitation,  
 Administering antibiotics,  
 Applying dressing to the wound     
   
• Late  
 Removal of dead tissue, escharotomy and skin grafting. 
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ANATOMY AND PHYSIOLOGY OF SKIN 
 
SKIN: - The affected organ. 
o Largest organ of the body[1] 
o Skin makes up about 15% of total body weight 
o The skin is the organ which is directly affected in burn injuries.  
It consists of two major layers[1]. 
Epidermis 
Dermis
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Epidermis:  
 
• The epidermis, a stratified squamous epithelium, is the outermost layer. 
• Normal turnover time of epidermis is 28 days.[1] 
• It is predominantly composed of keratinocytes (90%).[2] 
• Remaining 10% of epidermal cells are[2] 
o Langerhans cells 
o Melanocytes 
o Merkel cells 
• Proliferative compartment resides in the basal layer . 
 
• The  epidermis is very thick over the soles of the feet, and it is very thin  
 
over the ears. 
 
• Keratinized layer forms a protective seal between the organism and  
 
          the environment, protecting the skin from invasion by bacteria and other  
 
          foreign agents and it also prevents excessive loss of essential body fluids.  
 
            The epidermis has five layers: 
 
               Stratum corneum or corny layer [2] 
o It is formed of Horny cells which are the largest cells of the 
epidermis made up of dead, mature skin cells called keratinocytes. 
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o These cells are constantly replaced by cells from the basal layers of 
the epidermis.  
                  Stratum lucidum  
o This layer found only in thicker skin and helps to reduce friction 
between the corny layer and the granular layer. 
o The skin is thicker in some areas (like the soles of feet) and thinner 
in others; women also tend to have thinner skin than men do. 
               Granular layer or Stratum granulosum  
o The most apparent structures within these cells are basophilic 
keratino hyaline granules. 
o This layer is characterized by build-up of components necessary 
for the process of programmed cell death and formation of a 
superficial water impermeable barrier. 
               Spinous layer or Stratum spinosum  
o This layer named for the spine like appearance of the cell margins 
in histology. 
o These spines are abundant desmosomes, calcium dependant cell 
surface modification that promote adhesion of epidermal cells and 
resistance to mechanical stresses. 
                Basal layer or stratum germinativum or Stratum basale  
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o Deep most layer of epidermis. 
o This layer is attached to basement membrane.  
o It contains mitotically active keratinocytes and gives rise to 
superficial layer. 
o Malphigian layer includes both basal and spinous layer. 
               Basement membrane 
o It acts as an anchor for the epidermis.  
o It  allows movement of cells and nutrients between the dermis and 
epidermis. 
o The cell membrane of the epidermal basal cell is attached to the 
basement membrane via hemidesmosomes. 
o Lamina densa of basement membrane consists of type – IV 
collagen. 
               Dermis: 
o The dermis is vascular and supports the epidermis structurally and 
nutritionally. 
o  This layer is also where the vasculature and nerves live. 
o It varies in thickness. 
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o The  dermis consists of fibres including collagens I and collagen III, 
elastin and reticulin are synthesised by fibroblasts. 
o Support is provided by ground substances like glycosaminoglycans, 
hyaluronic acid and dermatan sulphate. 
o Depends on the pattern of collagen fibrils, superficial part of dermis 
is known as the ‘papillary dermis. 
o Deeper and coarser part as the ‘reticular dermis’.[3] 
o Cutaneous layer is formed by epidermis and dermis. 
o  Blood vessels, nerves, sweat glands, and hair follicles are found in 
dermis. 
        Functions of skin[2] 
        Major functions of skin are 
 Protection against disease  causing  particles. 
 Response to Sensory stimuli. 
 Vitamin D formation. 
 Exchange of waste. 
 Thermoregulation  
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WOUND HEALING 
o Repair and regeneration after injury of the tissue are fundamental defence 
mechanism of the body. 
o Totipotent cells are required for regeneration of multiple germ layers. 
o In a human outer and inner body coverings of epithelial layer retain 
regenerative property. 
o Skin, GIT, respiratory and urinary epithelial layer having the regenerative 
capacity after wounding. 
o Factors affecting wound healing[4, 5] 
 General factors 
 Old age – wound healing delayed. 
 Smoking – wound healing delayed. 
 Obesity 
 Vitamin deficiency 
    Vitamin c deficiency delays wound healing by defective 
collagen production. 
 Malnutrition- delays wound healing due to defective immunity. 
 Anaemia 
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 Uraemia 
 Diabetes 
 Jaundice 
 Immunosuppressive drugs like steroids and cytotoxic drugs. 
 HIV disease. 
 Other immunosuppressive drugs. 
 Local factors 
 Persistent  and recurrent trauma. 
 Infection in local area. 
 Presence of foreign body and unhealthy necrotic tissue. 
 Prolonged venous and lymph stasis. 
 Large size of wound. 
 Hematoma collection. 
 Tissues under tension. 
 Irradiation. 
 Dirty wounds. 
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 TYPES OF WOUND HEALING[7] 
 Healing by primary intention 
 Secondary intention 
 
o Primary healing 
 It is seen in clean incised wound and surgical wound when wound 
edges are closely approximated. 
 Epithelial regeneration occurs more than fibrosis in this type of 
healing. 
 Scar will be linear and smooth. 
o Secondary healing 
 This type of healing occurs when there is extensive loss of tissue as in 
major trauma , burn injury and sepsis. 
 Wound heals slowly. 
 Healing occurs with the formation of fibrosis , which results in 
formation of wide scar.  
o Stages of wound healing[6] 
 Stage of inflammation or lag phase or exudative phase 
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 Begins immediately and it lasts for 4-6 days.    
 Signs of inflammation - rubor ,tumour, color and dolor are seen. 
 Microscopic changes - Neutrophils appear after 48 hours which 
secrete mediators for inflammation  and also secrete bactericidal free 
radicals. 
 Chemical mediators involved and their actions are[8] 
Monocyte chemotaxis Chemokines, TNF, PDGF, FGF, TGF-β 
Fibroblast migration/replication PDGF, EGF, FGF, TGF-β, TNF, IL-1 
Keratinocyte replication HB-EGF, FGF-7, HGF 
Angiogenesis VEGF, angiopoietins, FGF 
Collagen synthesis TGF-β, PDGF 
Collagenase secretion PDGF, FGF, TNF; TGF-β inhibits 
HB-EGF, heparin-binding EGF; IL-1, interleukin 1; TNF, tumour necrosis factor 
 Proliferative phase or fibroblastic phase or collagenase phase 
 This phase begins in 1st week and lasts for 6 weeks. 
 Collagen and ground substance like glycosaminoglycans are  
produced by fibroblasts . 
 Collagen fibrils are produced by aggregation of tropocollagen 
which in turn formed by hydroxylation of proline and lysine. 
 90% of final strength is gained in 1 month. 
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 Remodelling phase or maturation phase 
 Begins in 6 weeks and lasts for 2 yrs. 
 Cross linking of immature collagen fibrils leads to formation of 
mature collagen.  
 The mature collagen is reason for tensile strength of the scar. 
 Wound contraction 
 It is an active process which occurs earlier and boosts secondary   
healing. 
 Contractile myofibroblasts appear in granulation tissue and 
cause rapid decrease in the size of large wounds. 
 Contraction of wound facilitates secondary healing and 
improves the functional as well as cosmetic results. 
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 TYPES OF BURN 
o Scalds 
o Flame burns 
o Flash burns 
o Contact burns 
o Electrical burns  
o Chemical burns 
o  Radiation burns 
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SPECIALIZED BURNS UNIT [25] 
• Improvements in burn care originated in specialized units specifically 
dedicated to the care of burned patients. 
• These units consists of experienced personnel with resources to 
increases the outcome from these severe injuries. 
• This unit consists of 
 Qualified and experienced Burn’s surgeon. 
 Dedicated and well trained nurses. 
 Physical and occupational therapist. 
 Dedicated Social workers. 
 Well experienced Dieticians. 
 Experienced Pharmacists. 
 Respiratory therapists. 
 Psychiatrists and Prosthetists. 
• Because of these available resources, patients with burns are best 
treated in these units. 
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The American burns association has given the criteria’s for transfer 
of a patient to a regional specialized burn centre[25]. They are 
o Patients  with Partial- thickness burns greater than 10% Total body 
surface area. 
o Burns involving  special areas of body such as face, hands, feet, 
genitalia, perineum and major joints. 
o Electrical burns and lightning injury. 
o Chemical burns. 
o Inhalation injury. 
o Burns which occur in patients with pre- existing medical disorders. 
o Patients with burns and associated traumatic injuries in which the burn 
is the greatest risk. 
o Burns in children without qualified personnel for the care of children in 
hospital. 
o  Patients with burns ,who will require special social, emotional or 
rehabilitative intervention. 
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CLASSIFICATION OF BURNS[6,12,18,19] 
Depending on thickness of skin involved
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a. First degree: Here the epidermis looks red and painful, no blisters, heals 
rapidly in 5-7 days by epithelialisation without scarring. 
 
 
b. Second degree: The affected area is mottled, red, painful, with blisters, 
heals by epithelialisation in 14-21 days. 
      -  Superficial second degree burn heals, causing pigmentation 
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- Deep second degree burn heals, causing scarring, and pigmentation
 
-  
-  
c. Third degree: The affected area is charred, parchment like, painless and 
insensitive, with thrombosis of superficial vessels. It requires grafting. 
Charred, denatured, insensitive, contracted full thickness burn is called as 
eschar. These wound must heal by reepithelialisation from wound edge. 
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d. Fourth degree: involves the underlying tissues, muscles and bones. 
 Involved 
area 
Pain  Adnexa  Appearance  Healing  
10 burn Epidermis  + + Erythema / 
oedema 
3-5 days 
20 burn Dermis  ++ + Blister, soft 
waxy white 
10 – 20 days 
with 
hypertrophic scar 
30 burn Full 
thickness 
__ Lost  Tough, 
Dry,Eschr 
3-5weeks, eschar 
separate, healing 
with SSG 
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a. Partial thickness burns: it is either first or second degree burn which is     
red and painful, often with blisters. 
b. Full thickness burns: it is third degree burns which are charred, 
insensitive, and deep involving all layers of the skin. 
Depending on the percentage of burns 
            Mild 
o Partial thickness burns < 15% in adult or < 10% in children 
o Full thickness burns less than 2% 
         Moderate 
o Second  degree of 15 – 25% burns ( 10-20% in children) 
o Third  degree between 2 – 10% burns 
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o Burns which are not involving eyes, ears, face, hand, feet, 
perineum 
         Severe 
o Second degree burns more than 25% in adults, in children more 
than 20% 
o All third degree burns of 10% or more 
o Burns involving eyes, ears, feet, hands, perineum. 
o All inhalation and electrical burns 
Burns with fractures or major mechanical trauma 
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 PATHOPHYSIOLOGY OF BURNS [8,9,10,16] 
 
o The degree and extent of injury will be determined by the temperature 
 
and magnitude of the burning agent and also by the duration of exposure 
of the offending agent. 
o Cellular injury begins at or above 440C. 
o Thermal injury can cause damage to capillary endothelium. 
o All burns leads to capillary damage and this is the cause of very large 
fluid loss that occur immediately after burns. 
o The RBCs are retained in the circulation, though they may be 
sequestrated by local stasis. 
o Because of this the peripheral resistance is increased, cardiac output is 
decreased due to reduction in the blood volume, thereby the viscosity of 
the blood is increased. 
o Loss of red blood cells associated only with deep burns.  
o The loss of red blood cells occurs in three distinct phases, which will not 
exceed 10% of total cell volume. 
 Actual destruction of RBCs by heat at the time of burning. 
 Becoming abnormally fragile and removed by the reticulo 
endothelial cells . 
 Unknown mechanism. 
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o Electrolyte changes  
The large volumes of fluid which move from one compartment to      
another in burns shock are associated with corresponding shifts of 
electrolytes. 
o Cytological damage  
1) Protein denatured.  
2) Thermo labile enzyme system blocked. 
3) Cell death occurs. 
o Inflammatory  responses 
 Accumulation of fluid in the wound. 
 Following mediators are released. 
 Thromboxanes 
 Vasoactive amines 
 Leukotrienes 
 Oxygen radicals 
 Lymphokines  
 Spasm of venules. 
 Vasoconstriction of arterioles. 
 Dilatation of capillaries. 
 Leakage of fluids, electrolytes and proteins.  
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o Burns shock  
It is due to 
 Increased capillary permeability 
 Increased fluid sequestration 
 Increased water loss 
 RBC’s are destroyed 
o Burn shock is the state of organ hypo perfusion in immediate post burn 
period because of lack of circulating volume. 
o Water loss is due to destruction of epidermis; occurs in acute and post 
resuscitation period. 
o Greatest initial volume loss is into interstitial space causing 
          Oedema, haematuria, renal shut down and ARDS. 
o Loss of capillary integrity mostly seen in first few hours. 
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PATHOPHYSIOLOGY 
         Burn coagulative necrosis 
 
           Cellular injury & inflammation    
 
                         Release of vasoactive substances 
 
                               
                             Increased capillary permeability 
                       
                           
 
                          Oedema                 Burn’s shock 
 
 
              Blister formation                  Hypovolemia 
 
 
                                                     Blood flow diversion 
 
 
                                                             Ischemia  
 
 
                                                     Renal          Gl mucosal necrosis 
  
 
                                                     ARF                Curling’s ulcer 
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Burn injuries can cause systemic as well as local changes. 
 LOCAL CHANGES 
     There are 3 zones noted in burned tissue   
 Central zone of ischemia or coagulation 
o Severe damage to tissues 
o Cells are destroyed by coagulation of its proteins  
 Zone of stasis or oedema 
o These are injured cells adjacent to central zone  
o These cells will die within 24 – 48 hours  
 Zone of hyperaemia 
o This is zone of minimal injury 
o This will recover within 7 days 
o Perfusion of tissue is increased
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ASSESSMENT AND MANAGEMENT OF BURNS [17,18,19,21,23,24,25]  
     INITIAL MANAGEMENT 
       PRE HOSPITAL 
• Burned patients must be removed immediately from the source of injury 
and the burning process should be stopped. 
• Inhalation injury is always suspected and 100% oxygen given to the patient by facemask. 
• All caregivers to the patients  should use universal precautions  
 
Including wearing gloves, aprons, face mask and protective eyewear 
 
like goggles whenever contact with the patient blood or the body 
fluids. 
• Burning clothes are removed as soon as possible. 
 
• Clean water of room temperature  can be poured on the wound 
 
      within 15 minutes of injury to decrease the depth of the wound. 
 
   INITIAL ASSESSMENT 
 
• Initial assessment of a burned patient is divided into a primary and 
secondary survey. 
• During primary survey, immediately life threatening conditions are quickly 
identified and treated. 
• During secondary survey, a more thorough head to foot evaluation of the 
patient to be done. 
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• Direct injury to the upper airway results in oedema, which together with 
the generalized whole body oedema associated with severe burns may 
have obstruction of the airway. 
• Airway injury must be suspected always with facial burns, singed nasal 
hairs, carbonaceous sputum and tachypnoea. 
• Progressive hoarseness is an early sign of impending airway obstruction 
and endotracheal intubation needs to be done before oedema distorts and 
obstruct the upper airway. 
• The chest is completely exposed in order to assess breathing. 
• Blood pressure may be difficult to measure in burns patients due to 
oedematous extremities. 
• The pulse rate can be used as an indirect measure of circulatory volume. 
• In patients who have been in an explosion may have the possibility of 
spinal cord injury they must be given cervical spine stabilization. 
PRE HOSPITAL WOUND CARE    
• Patient is wrapped in a blanket to minimize heat loss and for temperature 
control. 
• Burn wound requires protection from the environment with application of 
a clean dry dressing. 
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TRANSPORT  
• During transport of a burn victim it is important to have emergency 
equipment available along with trained personal on board such as nurses, 
physicians, paramedical personal or respiratory therapists who are familiar 
and  experience in managing  multiple injured trauma patients . 
                   
DEFINITIVE TREATMENT 
• Admit the patient in burns unit. 
• Maintain the airway, breathing and circulation. 
• Detailed history to be noted regarding patients name, age, sex, place & 
time of incidence. 
• History of present drug intake, chronic medical conditions, previous drug 
allergy and related injuries to be noted. 
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Assess the percentage of burns by ‘Wallace rule of nine’ 
 
      Body parts involved 
     
       % of burn 
 
 Each upper limb 
 Each lower limb 
 Head and neck 
 Front and back of trunk 
 Genitalia 
 
 
 
 
 
 9% of  TBSA 
 18% of TBSA 
 9% of TBSA 
 18% Each 
 1% of TBSA 
 
TBSA- Total body 
 Surface area  
 
• Depth of burn  
o Patients with burn wounds are needs to be reassessed in the first 48 -72 
hours because depth may increase due to inadequate treatment or 
secondary infection. 
o Burn wounds can be superficial in some areas and deeper in other areas. 
o Keep the patient in clean room. 
•  Burns unit is ideally air conditioned with barrier nursing, sterile clothes, 
bed sheets with all aseptic methods. 
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 FLUID RESUSCITATION  
Pathophysiology involved in fluid management 
o Burns injury causes an increased capillary leak in initial period leading 
to loss sodium and protein rich ECF fluid from intravascular 
compartment into area of burns so loss of sodium and protein rich fluid 
is at its greatest during the 1st 8 to 12 hrs. 
o The rate of loss of fluid and plasma volume decreases substantially by 8 
to 24 hrs.  
 
 
 Proper fluid therapy is important in burns patients because  
• Hypovolemia can lead to 
  - Shock and renal failure  
  - Rapid conversion of viable deep dermal burn to non viable full thickness    
    burn, which can increase mortality and morbidity . 
o Acute loss of protein due to leaky capillaries causes hypoproteinemia, 
which further increases oedema formation. 
o Aggressive fluid therapy can lead to 
    Massive tissue oedema leading to decrease in tissue perfusion and   
    oxygenation. This may result in further ischemic insult. 
 Objective of proper fluid therapy is to 
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o Restore and maintain adequate tissue perfusion . 
o Avoid organ ischemia. 
o Minimize the degree of tissue oedema . 
o Avoid detrimental effect of over resuscitation. 
 Initial fluid resuscitation(1st 24 hrs) 
o Ringers lactate is the most preferred fluid for initial resuscitation 
because 
- Composition of RL is most physiological, so large volume can be used 
without causing electrolyte derangements. 
- RL with a sodium concentration of 130mEq/L replaces large quantity of 
sodium and water lost from the intravascular space into the burn wound. 
       - It is free of glucose so safe in view of early glucose intolerance. 
- Lactate in RL is converted into bicarbonate which helps in correction of 
metabolic acidosis, commonly found in burns patients. 
o Volume of Hypertonic saline required for initial resuscitation is small as 
compared to that of RL. 
- Increased osmolality of hypertonic saline generates increased osmotic 
pressure, which shifts intracellular water to fill intravascular volume, and 
therefore it is effective in treating shock. 
- Benefit of hypertonic saline is seen in young patients with more than 
50% burns. 
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- Elderly burns patient with limited cardiac reserve with high risk of 
developing pulmonary oedema also gets benefited by resuscitation with 
hypertonic saline in order to decrease total volume of fluid 
administration. 
  - Hypertonic saline is used selectively and sparingly because margin of  
    safety is low and it requires extensive monitoring . 
- During the use of hypertonic saline serum sodium should not be allowed to  
   exceed 160mOsm/L . 
 Colloid infusion should be avoided in 1st 24 hrs because  
- It is not more effective than crystalloid in restoring the plasma volume  
during this period. Retention of colloid within circulation is no greater than  
the equal volume of RL. 
- Due to initial profound capillary leak, like circulatory protein even colloids  
infused will shift into the extravascular space. So it will exacerbate rather than  
improving the total body oedema.  
 Fluid therapy from 24 to 48 hrs 
    As the capillary permeability reduces significantly after 24 hrs, the rate of  
extravascular fluid loss is considerably less than that seen in the 1st 24 hrs. So  
lesser fluid volume is required in second 24 hrs. 
   Since burn tissues are saturated with sodium, they do not attract sodium and  
in turn water. So in the second 24hrs period, as the rule no sodium containing  
fluid is infused. 
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  Electrolyte-free, 5%-dextrose should be given in an adequate volume to  
maintain urine output and to provide adequate replacement for maintenance  
need and to cover evaporative water loss. 
   Similarly even capillary protein loss is sealed at this stage, so colloids can  
 be given safely to resolve plasma volume and to maintain cardiac output .    
 The volume of the fluid infused per hour should be roughly reduced by 25 to   
50 %.further modification is generally done by closely monitoring the urine  
output. 
 Fluid therapy after 48hrs. 
o Fluid requirement after initial 48 hrs of resuscitation is the sum of 
normal maintenance requirements plus replacement of abnormal 
losses.(including evaporate water loss and continuous loss of plasma) 
o Maintenance requirement contains chiefly water, sodium (3 mEq/kg) 
and potassium (2 mEq/kg). 
o Significant evaporate loss occurs from the wound surface at this which 
contains chiefly water. So to replace this loss salt free solution 5%-
dextrose is preferred. Volume required is 1ml/kg/% burns 
approximately. 
o Plasma loss occurs into burns tissue in deep burns and wound surface 
in superficial burns, which is replaced by dextrose saline, plasma or 
albumin with an aim to maintain serum albumin> 2.5 gm/dl. 
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o Correct anaemia by packed cell infusions maintaining haematocrit 
>35%  .     
 Formula to calculate the fluid replacement 
           A) Parkland’s formula: 
 It is  commonly used 
 4ml/%burn/kg body weight/24 hours. 
 Maximum percentage considered is 50%. 
 50% the volume is given in first 8 hours, rest given in 16 hours. 
B) Muir and Burclay regime: 
                        
                      % burns x body weight in kg                 = 1 Ration       
                                               2 
 3 rations given in first 12 hours 
 2 rations in second 12 hours 
 1 ration given in third 12 hours 
              C) Galveston regime (Paediatric) 
  
 500ML / m2 burned + 1500 ml/m2 total 
           D) Modified brookes formula 
• First 24 hours; 
                      RL; 4ml/kg/%burns In 24 hours (first half in first hours) 
• Second 24 hours  
• Crystalloids- to maintain urine output 
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•  Colloids -0.3ml to 0.5ml/kg/burns in 24 hrs  
              d) Evan’s formula- 
• In first 24 hours- 
o Normal saline 1ml/kg/% burns. 
o Colloids 1ml/kg/%burns. 
o 5% dextrose in water, 2000 ml - adult. 
• In second 24 hours 
o 50% of the volume used in first 24 hours. 
o Urinary catheterization should be done to monitor urine output; 30-
50ml/ hour should be the urine output. 
o Tetanus prophylaxis should be given. 
o Antibiotics: Aminoglycosides, penicillin’s, cephalosporins and 
metronidazole. 
o Respiratory management  
 Upper airway oedema of the pharynx, epiglottis and vocal cords 
are evaluated. 
 If mild oedema is noted, intermittent positive pressure ventilation 
with bronchodilator may be useful. 
 If severe laryngeal oedema is seen tracheostomy is recommended  
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Metabolic and nutritional needs  
 Total Kcal needs for a burns patient are based on age, sex, body size and 
severity of burn.  
 Commonly used Calculation: 
Kcal = Basal Energy Expenditure + Stress/Injury Factor 
 Most widely used formula for estimating Basal energy expenditure is the 
Harris Benedict Formula. 
 Harris Benedict formula for Males: 
Basal energy expenditure (kcal/day) = 66.47 + (13.75 X Weight) + (5 X 
Height) - (6.76 X Age) 
 For Females: 
Basal energy expenditure (kcal/day) = 655.1 + (9.56 X Weight) + (1.85 X 
Height) - (4.68 X Age) 
 Weight = Body weight in kg 
Height = Height in cm 
Age=Actual age in years 
 The stress factors used for burn patients are 
   Up to 20% total burned surface area = 1.0 - 1.5 
20 - 40% TBSA = 1.5 - 1.85 
Greater than 40% TBSA = 1.85 - 2.05 
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 Another formula used to calculate Basal energy expenditure is Curreri 
Formula: 
(25 kcal X body wt in kg) + (40 X % total body surface area burned) 
 The maximum of TBSA is limited to 50%.  
 Overfeeding can be as dangerous as underfeeding.  
 Complications of overfeeding are:  
o Hyperglycaemia  
o Hyperosmolality (lead to osmotic diuresis, dehydration, and 
ketotic  acidosis), and hepatic steatosis. 
 To over the negative nitrogen balance with major burn during the first 
month post injury and approximately 20gms. 
 Nitrogen /m2  per day during 2nd month 15gms must be given. 
 Vitamin supplementation and fat must be provided as follows 
o 1gm of ascorbic acid 
o 50mg of thiamine 
o 50mg of riboflavin 
o 500mg of nicotinamide 
o Twice the daily requirement of vitamin A&D 
o  Multivitamin infusion should be given 
o Blood transfusion given according to haemoglobin level  
o  Total Parenteral Nutrition is required for faster recovery 
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Protecting the gastrointestinal tract 
       1) The reflex ileus usually subsides by 48 to 72 hrs. 
 2) Neutralization of gastric contents and maintenance of gastric    
ph   above   7.0 protects against stress ulceration. 
 3) Intravenous injection of ranitidine 50mg twice daily and liquid 
antacid 10ml twice daily orally should be given. 
4) Ryle’s tube insertion initially for aspiration purpose and later for     
enteral feeding. 
o Culture from the wound and total white cell count at regular 
intervals are essential to identify the sepsis. 
          Indicators of adequate resuscitation 
1 Pulse < 120min 
2 B.P >120mm of Hg systolic 
3 Urine output 30-50 ml/hr or IMI /kg / hr 
4 CVP < 5-10 cm H2O 
5 Clear sensorium   
6 Normal PCWP 
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  Causes of failure of resuscitation 
1 Efforts are delayed 
2 Extent of injury under estimated 
3 Associated inhalation injury 
4 Third degree or fourth degree/electrical burns 
5 Myocardial depression  
6 Associated alcoholism/ heart diseases 
 
 
BASIC INVESTIGATIONS FOR A BURNS PATIENT 
 Complete blood count 
 Blood grouping and typing 
  Blood sugar and urea 
 Serum electrolytes 
 Pregnancy test in all females of childbearing age.  
 Arterial blood gas analysis 
 CXR and other X-rays if indicated  
 ECG 
 Serum proteins 
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LOCAL MANAGEMENT[26,27,28,29,33,37] 
 Initial cooling, cleansing and debridement should be done. 
 Determination of wound viability is one of the most difficult. 
 Dressing at regular intervals under anaesthesia using paraffin gauze, 
plastic films, hydrocolloids, Vaseline gauze or biological dressings to 
be done. 
 Open method with application of silver sulfadiazine without dressings 
can be done. 
 In closed method dressing to be done to soothen and to protect the 
wound to reduce the pain.  
 Tangential excision of burn wound with skin grafting can be done 
within 48 hours in patients with less than 25% burns. 
 It is usually done in deep dermal burn. 
 Slough excision should be done frequently. 
 Most commonly used topical microbial agents  are 
o Silver sulfadiazine-1% 
o Mafenide acetate-5% 
o Silver nitrate – 0.5% 
 Once the wound granulates well, usually SSG is done in 21 days. 
 If there is eschar, escharotomy is required to prevent compression of 
vasculature to the tissues. 
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ESCHAR 
o It is charred, denatured, full thickness burns with contracted dermis. 
o It has no sensation. 
o Thrombosed superficial veins are seen. 
o Circumferential eschar can cause more oedema which causes both 
venous as well as arterial compression thereby causing ischemia and 
gangrene of the distal part. 
o Escharatomy  
 Deep longitudinal full thickness incisions are made to prevent 
the oedema. 
 To protect the vessels getting compression by eschar. 
o Pseudoeschar is formed due to repeated silver sulphadiazine application 
to the burned skin. 
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COMPLICATIONS OF BURNS  
 IMMEDIATE COMPLICATIONS 
o Hypovolemic shock 
o Septicaemia and wound sepsis 
 The most common complication. 
 If untreated ends fatally. 
 Blood culture and sensitivity to be tested. 
 Antibiotics used according to report. 
 Wound sepsis is an imbalance in the normal equilibrium between 
bacteria and host resistance. 
 In wound sepsis increase in bacteria level from 103 organisms / gram 
of tissue to abnormal levels of > 105/ gram of tissue. 
 Clinical signs of wound sepsis are 
 Hyper or hypothermia 
 Respiratory distress or pulmonary oedema 
 Mental confusion 
 Local signs of wound infection 
 Conversion of second degree burn to full thickness burn. 
 Focal black discoloration of wound. 
 Degeneration of wound with new eschar formation. 
 Unexpectedly rapid eschar separation. 
 Haemorrhagic discoloration of subeschar fat. 
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 Erythematous and oedematous wound margin. 
 Crusted serrations of wound margin. 
 Histological criteria of burn wound infection 
 Dense microbial growth in eschar and subeschar space. 
 Haemorrhage in unburned tissue. 
 Microbes in unburned tissue. 
 Increased inflammatory reaction in adjacent viable tissue. 
 Perineural and intralymphatic migration of organisms. 
 Vasculitis with perivascular “cuffing” of organisms. 
 Small vessel thrombosis of ischemic necrosis of unburned tissue. 
 Microbial flora   
         - Clostridium tetani 
              -  Streptococcal infection 
               -  Pseudomonas 
o Duodenal and stomach ulceration 
- Superficial gastric erosions are common. 
- They are usually multiple in number . 
- They may be bleeding from this ulcers. 
- True duodenal ulcerations manifest 10 – 14 days after burn injury. 
- These ulcers are known as Stress or Curling’s ulcer. 
- Erosion in stomach and duodenum. 
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o Hypoproteinemia 
 Manifests as pedal oedema. 
 Treated with Fresh frozen plasma , astymin infusion and high 
protein diet. 
o Renal failure 
 It can occur in patient with large burn. 
o Liver necrosis 
o Necrosis of pancreas 
o Pulmonary complications 
o Cerebral oedema 
 INTERMEDIATE COMPLICATIONS 
o Glycosurea and hypoglycaemia 
 Transient glycosuria without ketonuria 
 exacerbation of pre existing diabetes mellitus 
o Pseudomonas septicaemia 
o Shock lung 
o Pneumonia 
o Suppurative thrombophlebitis 
o Decubitus ulcers 
o Constricting eschar 
o Pulmonary embolism 
o Osteochondritis 
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 LATE COMPLICATIONS 
o Contracture  
A) Complications of contracture 
 Ectropion of eyelid causing  exposure keratitis and corneal ulcer 
 Disfigurement of face 
 Restricted opening of mouth due to microstomia 
 Limited neck movements 
 Hypertrophic scar and keloid formation 
B) Treatment for contracture 
 Excision and release of contracture surgically and use of skin graft 
or ‘Z’ plasty 
 Appropriate physiotherapy to be given 
 Use of pressure garments 
C) Prevention of contracture formation 
 Appropriate Joint exercise in full range during recovery period 
 Proper use of pressure garments 
 Use of Saline expanders 
 Topical silicon sheeting 
o Hypertrophic scar 
o Pruritis 
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DIFFERENCES BETWEEN HYPERTROPHIC SCAR AND KELOID 
 Hypertrophic scar    Keloid 
o Relationship with 
the original wound 
 
 
o Regression  
 
o Familial  
o Race  
o Sex 
 
o Age group 
o Site  
 
o Cause 
o Histology 
 
 
o Immune system 
 
Rises above the skin 
level but stays within the 
border of the original 
wound 
Regress over time 
 
Non familial 
Not race related 
Men and women are 
equally affected 
Children 
Areas of tension and 
flexor surfaces 
Related to tension 
Collagen bundles are 
flatter and in a wavy 
pattern 
Higher T lymphocytes 
and Langerhans cell 
Rises above the skin level, 
extends beyond the 
confines of the original 
wound 
Rare spontaneous 
regression 
Familial 
More in Africans 
Women > men 
 
10- 30 years age 
Sternum, face, shoulder, 
ear lobe 
Unknown 
Collagen bundles arranged 
haphazardly and are larger 
and thicker  
ANA against fibroblast , 
endo and epithelial cells 
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 CAUSES OF DEATH IN BURNS 
o Asphyxia  
o Shock due to hypovolemia or septicaemia 
o Bronchopneumonia 
o Septicaemia 
o Exhaustion due to extensive burns 
o Rare causes – gangrene, tetanus etc. 
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SPECIAL TYPES OF BURNS [13,18,19,20,25] 
 CHEMICAL BURNS 
o In this type of burns tissue destruction is more 
o It is always deep burns 
o Types are acid burns and alkali burns 
 Acid burns  
o It occurs in GIT, skin and soft tissues 
o It is common in stomach among GIT either due to nitric acid or 
sulphuric acid which leads to gastritis and pyloric stenosis. 
o Acids cause metabolic acidosis, ARDS, renal failure and 
haemolysis. 
o Acidemia should be corrected  by IV sodium bicarbonate. 
 Alkali burns 
o It occurs in oral cavity and oesophagus . 
o Alkali burns in oesophagus causes multiple oesophageal strictures 
o Commonly involved alkalis are sodium hydroxide, potassium 
hydroxide, lime and bleach. 
o They cause saponification of fat, fluid loss, release of hydroxide 
ions which are toxic to cells. 
o External chemical burns are always deep and they can cause 
considerable disfigurement. 
o Initial treatment is dilution with clear water. 
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o Neutralization with antidote should never be done at initial  
management because it  causes exothermic reaction which 
aggravates the further tissue damage. 
o Later neutralisation can be done with 0.2% acetic acid in alkali 
burns and sodium bicarbonate in acid burns. 
o  Treatment  
• Mannitol diuresis 
• Haemodialysis if needed  
• Analgesics  
• Fluid and electrolyte management 
• TPN 
• Ventilator support if needed 
  
 INHALATION INJURY 
o It occurs due to 
 Inhalation of heat 
 Noxious gases 
 Products of combustion 
o At the incident site, if oxygen concentration is less, death can occur 
due to hypoxia. 
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o Inhaled CO can bind with haemoglobin in blood to form 
carboxyhaemoglobin causing severe anoxia and death. 
o Symptoms are 
 Disorientation and altered sensorium 
 Severe headache 
 Weakness 
 Visual disturbances 
 Hallucination  
 Shock  
 Laryngeal and bronchial oedema and finally spasm 
 Cardiac arrest 
o Late complications 
 Shock lung or Acute respiratory distress syndrome 
 Pulmonary oedema 
 Aspiration Pneumonia 
 Atelectasis 
 Pulmonary embolism 
o Clinical findings 
 ABG-Low oxygen saturation 
 Charring of mouth, oropharynx on bronchoscopic 
examination 
 Carbon sputum 
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 Singed nasal and facial hair 
 Altered mental status 
 Noisy breathing and dyspnoea 
o Treatment 
 Replace the patient from the fire site 
 IV antibiotics 
 Nasal oxygen therapy 
 Ventilator support if necessary 
 Bronchoscopy to confirm  
 Trecheostomy if required 
 ELECTRICAL BURNS 
o Two types are 
 High tension injury 
 Low tension injury 
o Electrical injury always causes deep burns. 
o Patient will have a wound of entry and wound of exit. 
o Victim may also have severe internal organ injuries. 
o Patient may develop convulsions. 
o Death can occur due to cardiac arrhythmias like ventricular 
fibrillation. 
o Renal tubular damage and renal failure can occur due to myoglobin 
release from muscles. 
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o Metabolic acidosis is common in electrical burns so patient often 
require bicarbonate infusion after confirmation by arterial blood gas 
analysis. 
o Orthopaedic problems like Fractures and dislocations can occur and 
are treated accordingly. 
o Investigations 
 Electro Cardiogram and cardiac monitoring 
 Chest X ray 
 Ultrasound abdomen  
 Computerised Tomography - Brain  
 Cardiac enzyme analysis by electrophoresis 
o Treatment 
 Wound excision and debridement 
 Amputation of limbs 
 Surgery for visceral injuries if necessary  
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TOPICAL ANTIBIOTIC THERAPY [25,26,28,29,32,33,35,37] 
 The most common cause of death in burns is sepsis. 
 Topical chemotherapeutic agents are applied  
o To limit excessive bacterial growth in the wound. 
o To prevent systemic sepsis. 
o To prevent destruction of viable tissue by progressive infection. 
 Ideal Topical Antimicrobial properties are 
o It should have properly targeted antimicrobial spectrum for the particular 
type of infected wound. 
o It should have rapid bactericidal activity. 
o It should have persistent or residual skin activity, allowing infrequent 
dosing. 
o It should have activity in the presence of body ﬂuids and  wound 
exudates. 
o Low likelihood of inducing bacterial resistance. 
o It should have local skin penetration . 
o It should not have systemic absorption. 
o It should not produce toxic or allergic reactions to host tissue. 
o It should be Cost effective. 
Advantages 
o High and sustained concentration of antimicrobial at the site of infection. 
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o Total amount of drug needed will be less . 
o Limited potential for systemic absorption and toxicity. 
o May help to reduce the use of systemic antibiotics. 
o Reducing development of antibiotic resistance. 
o It directs attention of patient to the wound. 
o It can be applied as outpatient, by patient or caregiver, thereby reducing 
the need for institutional care. 
Disadvantages 
o Only few effective agents have been proved by clinical trials. 
o Minimal penetration limits its use in open wounds without cellulitis or 
deep soft-tissue spread of infection. 
o Systemic absorption of some agents may occur.  
o Large size wounds. 
o Some agents cause local hypersensitivity reactions or contact dermatitis. 
o May interfere with wound healing processes. 
o It may cause possible alteration of normal cutaneous ﬂora. 
o Difficult to calculate accurate dose. 
o Frequent reapplications may be needed. 
o Sometime it may be difficult to apply or aesthetically unacceptable to 
some patients. 
 Commonly used topical agents in burns 
o Silver sulphadiazine1%  
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o Mafenide  
o Silver nitrate solution 0.5 % 
o Nitrofurazone 0.2% 
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Drugs used in this study are  
- Silver sulfadiazine  
- Placental extract 
    SULFONAMIDES [38,39,40,41] 
o The original antibacterial sulphonamides are synthetic antimicrobial 
agents that contain the sulfonamide group. 
o This group of drugs are able to interfere in normal cellular metabolism. 
Hence they are called antimetabolites. 
o Basically these drugs are bacteriostatic. 
o MOA: They are competitive inhibitors of folate synthase enzyme 
involved in folic acid synthesis metabolism. 
o Since they are competitive inhibitors ,inhibition is depend on the 
concentration of drug . 
o Hence inhibition can be reversible. 
o These drugs are selectively toxic to the bacteria and not to mammalian 
cells. 
o Because mammalian cells don’t produce folic acid. These cells use folic 
acid in diet . 
 
Drug classification 
 Oral agents 
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Short acting drugs Intermediate acting 
drugs 
Long acting drugs 
Sulfadiazine 
Sulfamethiazole 
Sulfisoxazole 
Sulfamethoxazole Sulfadoxime 
 
 Drugs used in GIT 
o Sulfasalazine 
o Olsalazine 
 Topical use 
o Silver sulfadiazine 
o Sulfacetamide 
o Mafenide  
Common uses 
o Sulfacetamide used in ocular infections. 
o SSD and Mafenide routinely used in burn patients. 
o Sulfasalazine used in ulcerative colitis. 
 
Common adverse effects 
o Hypersensitivity induced skin rash – most common . 
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o In HIV patients they can cause granulocytopenia and aplastic anaemia. 
o In G-6-PD deficiency patients these drugs can cause acute haemolysis. 
o These drugs precipitate in acid ph of urine results in hematuria and 
crystalluria. 
o Drowsiness and confusion  
o Steven- Johnson syndrome  
Metabolism  
o These drugs are metabolised in liver by acetylation.  
 Precautions 
o Liver failure 
o Renal failure 
o In case of prolonged use 
Drug interactions 
• These drugs are ineffective when pus is present.  
• Because pus large amount of Para amino benzoic acid which is 
competitive indicator of sulphonamide group of drugs. 
 
Contraindication 
           Pregnant women 
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ADVANTAGES OF SILVER DRESSINGS 
•  Release pure silver that is nontoxic to tissue. 
•  Release silver over days in antimicrobial quantities. 
•  Decrease mechanical trauma to the wound with no need for frequent 
dressing changes. 
•  Maintain moist wound healing. 
•  Silver ions exert immediate action against  microorganisms  and kill them 
by blocking their respiratory enzyme system.  
• Silver ions also have Pro- healing property by blocking matrix 
metalloproteinase activity. 
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PLACENTA [42 – 50] 
Derived from the Latin word meaning “flat cake”. In general refers to as 
“afterbirth”. 
Placenta contains 
 Over 128 rich growth factors( including HGF, NGF, EGF, IL2, IL3 
IL4) 
 Bioactive cytokines 
 Antibodies  
 Amino acids(valine, leucine and lysine) 
 Glycosaminoglycans 
 Nucleic acids 
 Hormones  
 Polydeoxy ribo nucleotides 
 Vitamins such as B2,B6,B12,folic acid 
 Minerals  
Placental extract 
 Placental preparations classified into 
o Aqueous extract 
o Hydroalcoholic extract 
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 The contents of the extract depends on the methods of preparation 
 Placentrex used in this study prepared in the following way 
o Fresh placenta stored in ice were tested initially for HIV antibody 
later for hepatitis surface antigen 
o Single cold and hot aqueous extractions were done at 6 and 900c 
respectively 
o Followed which sterilization done 
o It was filtered under aseptic condition and benzyl alcohol was 
added upto1.5% as preservative followed which sterilization 
done once again 
o Each ml of extract was derived from 0.1 gram of fresh placenta 
o A single batch was prepared from a single pool of several 
placenta 
    BENEFITS OF PLACENTAL EXTRACT 
 Anti aging 
 Wound healing 
 Boosting immune system 
 Mental alertness 
 Stamina 
 Vision improvement 
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 Regulating hormonal imbalances 
 Improving the overall physical activity 
Mechanism of placecental extract in wound healing 
 Human fibronectin type III like peptide ( peptide 7.2 kDa) found in 
placenta promote wound healing in the following ways 
 It can mediate Cell adhesion  
 Cell migration 
 Augment integrin signalling and induce expression of 
collagenase 
 The nucleotides  
 Increases tissue regeneration effect through protein synthesis. 
 NADPH – Important factor for synthesis of Nitric Oxide 
 Nitric oxide causes 
 Angiogenesis 
 Vasodilatation thereby improves tissue perfusion and facilitates 
the process of wound healing. 
 
 
 • 66 
 
 Antibacterial  action 
 Placental extract induces production of interferon – γ by 
macrophages.  
 Interferon –γ plays a major role in innate immunity and in 
inflammation. 
 Placental extract increases IgG and IgM antibodies and total 
lymphokines . 
 Both IgG and IgM activate the complement system which  in 
turn  produce specific antibodies thereby neutralise viruses and 
bacteria’s. 
 Regulation of protease activity 
 Proteases regulate the balance between tissue degradation and 
regeneration. So regulation of proteolysis activity is therefore 
critical for efficient wound repair. 
 Placental extract regulates proteolysis activity of certain 
proteases involved in healing. 
 It stabilises some proteolysis enzymes against their auto 
digestion and enhancing their efficacy in wound healing. 
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 Anti – inflammatory properties 
 Placental extract has anti –platelet aggregation activity, which is an 
important marker of inflammation. 
 Placental extract inhibit chemical mediators involved in inflammation. 
 Placental extract modulate the prostaglandin production,  thereby 
inhibit the platelet aggregation. 
 Placental extract also inhibit the serotonin release from the mast cells, 
is responsible for increase in vascular permeability during 
inflammation. 
 Collagen synthesis 
 Placental extract increases hydroxyproline synthesis which is 
responsible for collagen formation. 
      Possible side effects  
 Stinging sensations, 
 Burning sensations 
 Atrophy. 
 Signs of a reaction include difficulty in breathing, swelling, skin 
rashes, ect 
    Precautions 
 Any allergies 
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 Pregnant or breastfeeding 
 Taking any other medication  
 Any existing or past medical conditions which may relate to the 
condition being treated or interfere with this medication. 
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AIM OF THE STUDY 
The aim of the study is to analyse and compare placental extract and silver 
sulfadiazine application in 20 -40% fresh flame burns and scalds to compare 
the efficacy of both the drugs in 
1. Wound healing. 
2. Wound infection 
3. Contracture 
4. Hypertrophic scar 
5. Better patient compliance 
6. Cost effectiveness. 
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MATERIALS AND METHODS 
   STUDY POPULATION 
 The patient attending the emergency services and subsequent admission 
as in-patient (Age range of 13-70) with 20-40% fresh flame burns and 
scalds in CMCH . 
   STUDY PERIOD 
       September 2011 to November 2012 
   STUDY DESIGN 
        Randomised control prospective study 
 
• Soon after the patients are admitted in the ward, detailed history taking 
will be followed in all the cases 
• Patients with disease which delays wound healing like diabetes melitus, 
tuberculosis, anaemia, organ failure, immuno compromised status, and 
previous drug intake etc will be noted. 
• Thorough clinical examination of the patients will be made and 
percentage of body surface area involved will be recorded according to 
the rule of 9. patients admitted with 20 – 40 % burns are randomised into 
two groups 
• Both the groups were carefully selected to match as closely as possible 
for age, sex and burns surface area. 
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• In both the groups patients were treated after getting oral as well as 
written consent.  
• In group I patients were treated with placental extract application along 
with fluid resuscitation and intravenous antibiotics. [protocol followed in 
CMCH] 
• In group II patients were treated with silver sulfadiazine application along 
with fluid resuscitation and antibiotics. 
• The burn wound is cleansed with saline and topical agent (placental 
extract or SSD) applied directly over the wound using sterile gauze in 
daily morning. 
• During the treatment period  the patients will be examined  for   
 Healing of burn wound 
 Wound infection 
 Eschar formation  
 Wound contraction 
 Granulation tissue formation   
 Burning sensation on application of drug and 
 Wound status will be noted. 
• Wound swab will be taken from the burn wound on the day of admission 
and 5th day in the post admission period. 
 • 72 
 
• After obtaining culture and sensitivity report patients were given 
antibiotics according to the report. 
•  90% healing was chosen as our-endpoint as the healing of the rest of the 
wound to completion is generally variable and dependent upon other 
factors like age, depth and % of burns. After the patients are discharged 
from the Hospital regular follow-ups will be done for first two months. 
• During the follow up period, the patients are examined for 
  Hypertrophic scar 
  Contracture 
     INCLUSION CRITERIA  
 All patients age range of 13 – 70  
  20 – 40%  burns 
 Flame  burns and scalds  
  First and second degree burns 
 <24 hrs time interval between incident and hospital admission of the 
patient. 
      EXCLUSION CRITERIA 
 Any patients less than 13 years and greater than 70 years of age. 
 Patients having burns other than flame burns and scalds. 
  >24 hrs of time interval between incident and hospital admission. 
 • 73 
 
 Patients with disease which delays wound healing like Diabetes 
Mellitus, Tuberculosis, Leprosy, Anaemia; Immuno compromised 
status, Organ failure and chronic drug intake. 
 Death of the patient during study period. 
 OBSERVATION AND RESULTS 
I.PATIENT CHARECTERISTICS 
 
 
 
 
 
 
 
 
 
0
5
10
15
20
25
20 - 30% 31 - 40%
<40 YEARS
placental extract
SSD
AGE        % 
BURNS 
  PLACENTAL   
EXTRACT 
            SSD 
BELOW 
40YRS 
20-30%           25 [53%]            24 [51%] 
31-40%           12 [26%]            13 [28%] 
ABOVE  
40YRS 
20-30%             7 [15%]              6 [13%] 
31-40%             3 [6%]              4 [ 8%] 
           
Total           47[ 100%]            47 [ 100%] 
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In this study patients with 20 – 30% burns are more in number 
than patients with 30 – 40 % burns 
 
Sex distribution  
GROUP  MALE FEMALE TOTAL 
PLACENTAL 
EXTRACT 
0 47 [ 100%] 47 [ 100%] 
SSD 2 [ 4.3%] 45 [95.7%] 47 [100%] 
 
0
1
2
3
4
5
6
7
20-30% 31-40%
>40 years
placental extract
SSD
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In this study female patients are more in number than males  
 II.INFECTION 
GROUP INFECTION 
PRESENT 
INFECTION 
ABSENT 
TOTAL 
PLACENTAL 
EXTRACT 
20 [43%] 27 [57%] 47 [100%] 
SSD 14 [30%] 33 [70%] 47 [ 100%] 
                                                               P = 0.1978 
There is NO significant difference in both the groups 
 
 
0 10 20 30 40 50
placental extract
SSD
female
male
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Though infection rate is more in placental extract 
group than in SSD, statistically it is insignificant 
 
Distribution of infecting organisms 
 Pseudomonas  S. Aureus Klebsiella  others Total  
Placental 
extract 
 9(45%)  5(25%) 2(10%) 4(30%) 20 
(100%) 
SSD 6(43%) 3(21%) 2(14%) 3(22%) 14 
(100%) 
 
0%
10%
20%
30%
40%
50%
60%
70%
80%
infection present
infection absent
INFECTION
placental extract
SSD
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In both the groups Pseudomonas infection is common 
 
 
III. WOUND CONTRACTURE 
GROUP PRESENT ABSENT TOTAL 
PLACENTAL 
EXTRACT 
12 [ 26%] 35 [74%] 47 [100%] 
SSD 15 [32%] 32 [68%] 47 [100%] 
 
                                                                 P= 0.4941 
placental extract
SSD0
1
2
3
4
5
6
7
8
9
ORGANISMS CULTURED
placental extract
SSD
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There is no significant difference in both the groups 
 
 
 
IV. HYPERTROPHIC SCAR 
 
GROUP PRESENT ABSENT TOTAL 
PLACENTAL 
EXTRACT 
16 [34%] 31[ 66%] 47 [100%] 
SSD 21[ 45%] 26 [55%] 47 [100%] 
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WOUND CONTRACTURE
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                                                    P =0.2912 
There is no significant difference in both the groups 
 
 
 
V. BURNING SENSATION ON APPLICATION OF DRUG 
 
GROUP PRESENT  ABSENT TOTAL 
PLACENTAL 
EXTRACT 
6 [13%] 41[87%] 47 [100%] 
SSD 14 [28%] 33 [72%] 47 [100%] 
 
0% 20% 40% 60% 80%
hypertrophic scar present
hypertrophic scar absent
HYPERTROPHIC SCAR
SSD
PLACENTAL EXTRACT
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                                                                P = 0.0438 
There is significant difference seen 
 
 
 
VI. WOUND HEALING 
90% OF WOUND 
HEALING IN 20 – 
30% OF BURNS 
PRESENT ABSENT TOTAL 
PLACENTAL 
EXTRACT 
25 [78%] 7 [22%] 32 [100%] 
SSD 12 [ 40%] 18 [60%] 30 [100%] 
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burning sensation absent
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                                                P = 0.0022 
 
There is significant difference seen in both group 
90% OF WOUND 
HEALING IN 20DAYS 
FOR 31-40% 
PRESENT ABSENT TOTAL 
PLACENTAL EXTRACT 11 [73%] 4 [27%] 15 [100%] 
SSD 6 [35%] 11 [65%] 17 [100%] 
 
                                                     P = 0.0314 
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wound healing present
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Significant difference noted in both groups 
VII. DURATION OF HEALING 
                                      GROUP PLACENTAL 
EXTRACT 
SSD 
 AVERAGE 
DURATION 
[ DAYS] 
20-30% BURNS 17 DAYS 26 DAYS 
31-40%  BURNS 21 DAYS 29 DAYS 
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        VIII. COST EFFECTIVENESSVENESS 
             PLACENTAL EXTRACT:  
o 10%  burns needs 20gms of gel per day 
For 20- 30% healing requires 17(days) x 60 gms 
o Price 20gms= Rs.74 
o So 17x [74 x 3]= About Rs. 3774/ - 
o For 100 patients Rs.3,77,400 
o For 31 – 40% = Rs. 6216 /- 
o For 100 patients Rs.6,21,160 
             SSD 
o 10% of burns needs 100gms of gel per day  
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o For 20 - 30% of healing requires  26(days) x 300gms 
o Price 100gms= Rs.75 
o So 26 x [75 x 3]= Rs.5850 /- 
o For 100 patients Rs.5,85,500. 
o For 31 – 40% = Rs. 8700/- 
o For 100 patients Rs.8,70,000 
 
Placental extract is cost effective 
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DISCUSSION 
 Our study included of 94 cases of 20 – 40 % burns the burns were most 
commonly found in females and male to female ratio was 1:46 in our 
study population.   Female predominance occurs due to  
1. The working atmosphere in kitchen . 
2. Involvement in dowry problems . 
3. Stressful life . 
4.Handling of combustible fuel and volatile gas. Kerosene   can easily 
spill and is highly combustible. Accidents are possible while handling.   
        This is in concurrence with the following previous study- 
 Ashish K Jaiswal et al, Epidemiological and socio-cultural study of burn 
patients in M. Y. Hospital, Indore, India 
 Burns were more commonly occurs in people <40 yrs. This is 
comparable with previous study  
Ashish K Jaiswal et al, Epidemiological and socio-cultural study of burn     
patients in M. Y. Hospital, Indore, India 
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      This is due to  
 Most common complication of burns in our study population is wound 
infection, which occurred in 30 – 40 %.The most common causative 
organism was found to be pseudomonas followed by S.Aureus.  
 This is comparable to the following study 
Bacterial isolates from burn wound infections and their antibiograms: A 
eighty-year study, Manjula Mehta, Priya Dutta, Varsha Gupta et al 
Molecular epidemiologic study of burn wound infection caused by 
Staphylococcus aureus in children, wu sx, liu yx et al. 
The Epidemiology of Burn Wound Infections: Then and Now Robert A et   
al 
 Complications were higher in the above 40 yrs age group in patients with 
higher % of burns in our study. This results correlates with Ashish K 
Jaiswal et al, Epidemiological and socio-cultural study of burn   patients 
in M. Y. Hospital, Indore, India. 
 We divided the study population randomly into two groups. One 
receiving placental extract and the other receiving silver sulfadiazine, 
matching regarding age and % of burns was done in each group . 
 The infection pattern of the burns was studied by wound culture and 
sensitivity the cultures were taken on the day of admission and 5th day, 
from which the organisms and sensitivity studied. 
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 Wound infection was found to slightly higher in the group receiving 
placental extract which was further higher in the patients coming under 
age group of >40 years. 
 The statistical calculation was done using chi-square-test which showed 
no significant difference between the two drugs. This may show that 
though the placental extract is a drug for wound healing it may have 
antibacterial activity equivalent to silver sulfadiazine. The profile of 
organisms grown was similar in both the groups. 
 Wound contractures slightly higher in silver sulfadiazine but it showed 
no statistical significance. Similarly there was no statistical significant 
difference between prevention of hypertrophic scar in both the groups. 
Thus the prevention of long term complications were not significantly 
different between either of the drugs this may be due to fact that 
development of hypertrophic scar and contracture may depend upon 
other factors like physiotherapy received and patients genetic profile. 
 This may also be due to the fact that application of both the drugs was 
stopped once the epithelisation has occurred and the initial scar may 
progress to hypertrophic scar after the initial epithelisation. 
 The major difference between two drugs was found in the patient 
compliance and wound healing. 
 Burning sensation in patients treated with placental extract was 
significantly lower when compared to those who got silver sulfadiazine 
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this improved patient toleration of the drug and prevented 
discontinuation of the treatment. 
 20 days was kept as a cut-off point to study the difference in wound 
healing in both groups. Because more than 50% of patients had 
comprehensive wound healing within this time. This was in 
concurrence with various other studies in wound healing in burns 
patients. 
 Wound healing was significantly higher in patients using placental 
extract in both 20 -30 % and 31 – 40 % burns . 
 This is comparable to the study conducted by shukla et al, role of 
placental extract in wound healing. 
 The number of patients who had 90% wound healing within this period 
were the most double in patients using placental extract when compared 
to those using silver sulfadiazine. 
 The major point of consideration when comparing two treatment 
options is the cost effectiveness of the treatment . 
 The cost of using placental extract for healing of 20 – 30 % burns was 
Rs-3774/- Which was significantly lower than when compared to silver 
sulfadiazine which came up to Rs 5850/, the gap was further increased 
when the % of burns increased. 
 Thus placental extract is a cheaper and more effective treatment option 
in burns wound healing. 
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 CONCLUSION 
In this study of 94 patients with the following conclusions have been 
arrived 
 Incidence is higher among females than males. 
 The Peak incidence occurs in the age group of less than 40 years. 
 Pseudomonas aeruginosa and staphylococcus were the most commonly 
incriminated organisms in burn wound infection. 
 Placental extract has better patient compliance. 
 Placental extract is cheaper and cost effective. 
 Placental extract is effective in burns wound healing. 
 Both silver sulfadiazine and placental extract are not effective against 
development of hypertrophic scar and contracture . 
 Further studies may be required to know about the effect on preventing 
late complications in burns using placental extract.  
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   PROFORMA 
 PATIENT PARTICULARS 
• Name  
• Age  
• Sex 
• In-Patient no 
• Address 
• Place and time of incidence 
• Type burns 
 PAST HISTORY 
• DM/ HT/ TB/ Anemia/ BA/ Epileptic 
• Previous Drug intake  
• Any previous H/O Drug allergy  
 PERSONAL HISTORY 
• Smoker/ Alcoholic 
 MENSTRUAL HISTORY 
 GENERAL EXAMINATION 
• Anemia 
• Jaundice 
• Pedal oedema 
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• Generalized lymphadenopathy 
 SYSTEMIC EXAMINATION 
• CVS 
• RS 
• ABDOMEN 
• CNS 
 % OF BURNS BY ‘RULE OF NINE’
 
 PARKLAND’S FORMULA 
4 X % Burns X Total body weight 
Half of the calculated fluid to be given in fisrst 8 hours 
Rest of the fluid to be given in next 16 hours 
 
 INVESTIGATIONS 
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• Complete blood count 
• Blood grouping and typing 
•  Blood sugar and urea 
• Serum electrolytes 
• Pregnancy test in all females of childbearing age.  
• Arterial blood gas analysis 
• Serum proteins 
• ECG 
• CXR  
• Wound culture and sensitivity 
 
 TREATMENT 
• Intravenous fluids 
1st 24 hrs – crystalloids 
   24– 48 hrs – colloides 
• Antibiotics 
• Topical drug application 
 Placental extract or  SSD – immediately after admission and 
once in 24 hrs 
 OBSERVATION  
• Wound healing 
• Wound infection 
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• Burning sensation on application of drug  
 FOLLOW UP 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 Patient with 30% burns on admission 
 
 
 
 
 
 
 
 
 
The same patient treated with placental extract 
 
 
  
 
 
 
 
  
 
Patient with 35% burns on admission 
 
 
 
The same patient  - placental extract applied 
 
 
  
Application of silver sulfadiazine 
  
 
 
Name Age IP NO % Burns Infection ContractureHypertroph  Burning sen    90% HEALIN    Duration  of haeling(days)
HAVAMAN 44/F 57783 20% P N N N P 20
SAROJA 45/F 7487 20% N N N N P 14
GAMATHY 64/F 10625 20% P P N N P 17
GOMATHI 66/F 20290 20% P N N P N 18
REETHA 24/F 19377 20% N N N N P 16
NISHA 24/F 19415 20% N N N N P 19
NEELAVEN 24/F 38860 20% N N N N P 15
UMA 35/F 39082 20% P N N N P 18
VAGAYATH 16/F 51368 20% N N N N P 16
AKILA BAN 36/F 52377 20% N P P N P 17
ARIAMMA 65/F 8139 25% P N P P P 19
NATHIYA 22/F 456 25% N N N N P 15
AHIRA BA 26/F 15226 25% N N N N P 18
REVATHI 25/F 23121 25% N N N N P 17
USHA 23/F 36215 25% N N N N P 16
JOTHIMAN 38/F 36214 25% P N P N N 17
HINNAMMA 70/F 12652 30% P P P N P 16
RAMATHAL 70/F 20097 30% P N N N P 17
SOBANA 16/F 227 30% N N N N P 18
CHITRA 25/F 3363 30% P N P N N 17
ARUPATHA 27/F 10628 30% N N N N P 17
BANU 27/F 14220 30% N P P N N 16
MAMUTHA 24/F 23139 30% P N N N P 18
ADHAMAN 26/F 30158 30% N N N N P 17
DHILSATH 28/F 3964 30% N N N N P 17
ARASWATH 40/F 30467 30% P P P N N 16
SIVAGAMI 35/F 32800 30% N N N N P 18
SAMSATH 25/F 34679 30% N N N N P 17
NDIYAMM 40/F 35718 30% P N N N P 16
APROJ 27/F 36060 30% N N P N P 18
SASIKALA 31/F 36063 30% N P P P P 17
RANDISELV 23/F 51352 30% N N N N P 17
VEERATHA 61/F 40372 35% P N N N P 22
NAGALAKS 38/F 19173 35% N N N N P 20
MANJULA 28/F 19250 35% N N N N N 23
MALLIKA 40/F 38652 35% P P N N P 19
USHA 47/F 17128 40% P N P N P 21
ASMABEEM 45/F 46632 40% P N P N P 23
RANI 28/F 5673 40% N P N N P 19
VASANTHA 28/F 28140 40% N N N N P 21
NAGAMMA 34/F 39370 40% P P P N N 21
EPSIBHA 40/F 43465 40% P P N N P 23
KAVITHA 24/F 45008 40% N N N N P 19
AHESHWA 39/F 47476 40% P N P P N 20
VANITHA 27/F 45225 40% N P P N P 22
AMUDHA 21/F 67115 40% N P N P N 21
PREETHI 27/F 68086 40% P N P N N 21
NAME AGE/ SEX IP NO % BURNS INFECTION CONTRACT HYPERTROP  90% HEALIN    
PAPPATHY 65/F 22601 20% P N P P
NEELAMAN 45/F 26323 20% P N N P
ESWARI 45/F 27368 20% N P P N
SARANYA 19/F 4383 20% N N N P
DHANALAKSH 35/F 24431 20% N P P N
BHUVNANEESH 23/F 25262 20% N N N P
NANDHINI 20/F 35352 20% N N N P
KANNAPPA 35/M 36231 20% P N P P
VIJAYALAKSH 38/F 45179 20% N N P P
SATHYA 28/F 48377 20% N N N N
MYLATHAL 60/F 50680 25% P N N P
AMMASAI 65/F 50922 25% P N N N
SASIKALA 26/F 39362 25% N N P P
RAJAMAN 30/F 49349 25% N N N P
RAMATHAL 35/F 43605 25% N N P P
ANITHA 34/F 47790 25% N N P P
ARUKKAN 46/F 46282 30% P N P P
SHAKILA 35/F 51373 30% N N N P
PANDIAMMA 40/F 51087 30% P P P P
SUMATHY 24/F 55721 30% N N N P
JERINA BAN 29/F 58012 30% N N N P
RADHAMAN 37/F 62083 30% N P P P
SNGEETHA 24/F 64181 30% N N N P
USHA RAN 30/F 74345 30% P P P P
JESSE 30/F 3523 30% N P P P
GOKILA 17/F 1978 30% N N N P
NETHRAVAT 26/F 28239 30% N N N P
THARA 34/F 35061 30% P P P P
PARVATHY 25/F 35984 30% N P P N
ARTHI 20/F 45120 30% N N N P
SELVI 45/F 4547 35% P N N P
LAKSHMI 30/F 39683 35% N P P P
JAYALAKSH 26/F 12878 35% N N N P
KARTHICK 22/M 34639 35% N N N P
SAKTHI 25/F 49422 35% N N P N
AJMUNISHA 58/F 56215 40% N P P P
ARULMAN 65/F 17942 40% P N N P
ARUKKAN 46/F 18131 40% P N P P
VANITHA 24/F 73977 40% N P P N
VANITHA 28/F 2660 40% N N N P
MUTHULAKSH 16/F 13107 40% N N P N
GEETHA 25/F 14893 40% N P P P
KARTHIGA 28/F 20448 40% N P P N
SANGEETH 20/F 35194 40% N N N P
SUNITHA 35/F 36167 40% P N P P
REVATHI 35/F 42000 40% N P P N
LATHA 33/F 42109 40% P P P N
DURATION OF HEALING IN DAYS
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